Browse by Title

• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z
• #

• D
• Debate: HIPEC in Ovarian Cancer in the US
  Favorite
  Stephanie L. Wethington, MD, MSc – Johns Hopkins University School of Medicine ### 934672###Lecturer @@@ Oliver Zivanovic, MD – Memorial Sloan Kettering Cancer Center ### 937284###Lecturer
• Defining ‘Complete Cytoreduction’ after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis (PM5)
  Favorite
  Carlos A. Munoz-Zuluaga, MD – Mercy Medical Center ### 915781###Oral Abstract Presenter PM5
• Definition and Prediction of Early Recurrence and Mortality Following CRS HIPEC: Predicting Futility Preoperatively (PM11)
  Favorite
  Caroline Rieser, MD – University of Pittsburgh Medical Center ### 915790###Oral Abstract Presenter PM11
• Developing Prospective Databases and Collaborations
  Favorite
  Shishir K. Maithel, MD – Emory ### 917909###Speaker